Medical/Pharmaceuticals

Get Race-Ready for KLSCM 2025 with Pantai Hospital Kuala Lumpur

A Hospital That Runs With You KUALA LUMPUR, Malaysia, Sept. 26, 2025 /PRNewswire/ -- As the countdown begins to the Kuala Lumpur Standard Chartered Marathon (KLSCM) 2025, thousands of runners are training hard to hit their personal bests. But while most are focused on mileage, timing, and gear, ...

2025-09-26 13:51 2291

Tourism Malaysia and MHTC Bring Malaysia Fair 2025 to Surabaya A Celebration of Culture, Cuisine, Travel, and Healthcare Excellence

SURABAYA, Indonesia, Sept. 26, 2025 /PRNewswire/ -- Tourism Malaysia, in collaboration with the Malaysia Healthcare Travel Council (MHTC), proudly presents Malaysia Fair 2025—a four-day celebration ofMalaysia's culture, cuisine, tourism, and healthcare excellence. Taking place at Pakuwon Mall, Su...

2025-09-26 09:45 2621

Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida

Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New headquarters designed to support innovation, collaboration and growth TAMPA, Fla., Sept. 26, 2025 /PRNewswire/ -- Catalent, Inc., the leader in enabling the developmen...

2025-09-26 09:00 1724

Building a National Lung Cancer Screening Model with AI: Early Lessons from Australia

BRISBANE, Australia and SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- Coreline Soft announced today it will host an international webinar on Tuesday, October 14, sharing firsthand experiences and insights fro...

2025-09-26 07:00 1769

iotaMotion Surpasses 1,000 Clinical Procedures Performed with iotaSOFT® --Defining a New Era in Cochlear Implant Surgery

* Fewer than 5% of eligible patients worldwide receive cochlear implants today * Hearing loss is the largest modifiable risk factor for dementia, linked to approximately 8% of global cases — more than hypertension, obesity, smoking, or depression ST. PAUL, Minn., Sept. 25, 2025 /PRNewswire/ -- ...

2025-09-25 20:33 1376

C2F Empowers Chula to Advance Academic Excellence and Research on the Path to Becoming a World-Class University

BANGKOK, Sept. 25, 2025 /PRNewswire/ -- The C2F, or Second Century Fund , of Chulalongkorn University supports research that addresses social, environmental, economic, and national policy challenges. In 2025, over 1,000 scholarships will be awarded, with nearly700 millio...

2025-09-25 10:00 1627

Sky Labs Launches CART BP, a Ring-Type Cuffless Blood Pressure Monitor

App-based "Blood Pressure Calendar" enables 24-hour tracking, including nighttime measurements SEOUL, South Korea, Sept. 25, 2025 /PRNewswire/ -- Sky Labs announced the official launch of CART BP, a ring-type personal blood pressure monitor designed for everyday use.

2025-09-25 06:00 1786

ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT

Fourth annual report highlights continued progress in sustainable innovation, safety, and responsible resource stewardship BUFFALO GROVE, Ill., Sept. 25, 2025 /PRNewswire/ -- Advancion Corporation ("Advancion" or "Company"), a global leader in life science buffers and proprietary specialty ingre...

2025-09-25 02:40 1437

Suvoda and Greenphire complete brand integration with unified website and social media presence

CONSHOHOCKEN, Pa., Sept. 25, 2025 /PRNewswire/ -- Suvoda LLC , a global clinical trial technology company, today announced the completion of its brand integration with Greenphire,...

2025-09-25 00:01 1640

MindHYVE.ai™ Unveils ChironAI™: The World's First AGI-Powered Clinical Decision Support System, Redefining Healthcare Intelligence

NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an autonomous, next-generation Clinical Decision Support (CDS) system powered by the revolutionary Ava-Healthcare™ AGI reasoning model. Designed from the ground up t...

2025-09-24 22:40 1618

The Hidden Genetic Threat Putting 1 in 5 at Cardiovascular Disease Risk: Global Experts Call for Action on Elevated Lipoprotein(a)

* Cardiovascular disease (CVD) kills nearly 18 million people each year, more than all cancers combined1,2 * Elevated lipoprotein(a) or Lp(a), an inherited condition that raises CVD risk, affects 1 in 5 people worldwide but is rarely tested3 * New survey across Asia Pacific and Middle East s...

2025-09-24 20:21 1584

Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)

SHANGHAI, Sept. 24, 2025 /PRNewswire/ -- Hengrui Pharma (600276.SH; 01276.HK), a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced today that it has entered into an exclusive license agreement with Glenmark Specialty S.A. (GSSA), a whol...

2025-09-24 19:45 1768

Xinhua Silk Road: Guotai Haitong Securities hosts conference on biopharma and AI in E. China's Shanghai

BEIJING, Sept. 24, 2025 /PRNewswire/ -- The 2025 Shanghai pioneering industries conference, hosted by Guotai Haitong Securities, was recently held in east China's Shanghai. The event also featured the 14th pharmaceutical CEO forum and the 5th artificial intelligence (AI) conference. The event bro...

2025-09-24 09:02 2473

LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly

NORWALK, Conn., Sept. 24, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and development collaboration with Eli Lilly and Company ("Lilly") focused on advancing innovative ...

2025-09-24 00:15 1307

TraceLink Delivers Intelligent Productivity Gains with OPUS Platform Expansion

BOSTON, Sept. 24, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced powerful new capabilities in its Orchestration Platform for Universal Solutions (OPUS) designed to unlock unprecedented productivity...

2025-09-24 00:12 1311

LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support Services

JOHNSON CITY, Tenn., Sept. 23, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, announces a strategic collaboration with The Bracken Group to enhance its radiopharmaceutical support capabilities. As demand for radiopharmac...

2025-09-23 21:15 1215

Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions

CARLSBAD, Calif., Sept. 23, 2025 /PRNewswire/ -- Pictor Holdings Inc., a global leader in targeted, multiplex proteomics, today announced the close of a convertible note funding round led by existing investors. The raise underscores strong confidence in Pictor's strategic expansion and recent est...

2025-09-23 21:00 1552

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics

2025-09-23 20:01 1299

Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress

CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- The 2025 European Society for Medical Oncology (ESMO) Congress will take place inBerlin, Germany, from October 17 to 21. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) will present results from multiple clinical stud...

2025-09-23 17:03 1668

Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC

CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged during transfection (RET) kinase inhibitor A400 (also known as EP0031) was accepted for review ...

2025-09-23 10:22 1438
1 ... 19202122232425 ... 397

Week's Top Stories